Fargo Hosts Fourth Annual Bioscience Summit
The two-day event connects regional researchers and industry leaders to accelerate the commercialization of new biotechnology.
Updated on Oct. 21, 2026 in Biotech
Live Poll
Do you believe your local community should prioritize investment in the regional bioscience industry?
More than 150 professionals gathered at the Avalon Events Center in Fargo for the Fourth Annual Bioscience Summit. The two-day event focused on industry trends, capital investment, and local workforce development.
Why it matters
The summit highlights a regional industry that generated $227.1 million in gross product in 2021, serving as a hub for connecting academic research with commercial biotechnology applications.
The regional bioscience sector generated $227.1 million in gross product against $89.6 million in earnings during 2021. Meanwhile, the University of North Dakota School of Medicine & Health Sciences sustains an annual research volume exceeding $40 million.
The players
Aldevron
A developer and manufacturer of high-quality plasmid DNA, proteins, and enzymes used in the production of gene and cell therapies.
CorVent Medical
A medical device company focused on developing flexible, scalable respiratory support systems for critical care environments.
Genovac
A contract research organization specializing in antibody discovery and development for therapeutic and diagnostic applications.
Agathos Biologics
A biotechnology company focused on developing advanced cell culture media and bioprocessing solutions.
University of North Dakota School of Medicine & Health Sciences
A research institution focused on biomedical science that conducts over $40 million in research annually.
The details
The summit serves as a collaborative venue for researchers, economic development officials, and private industry leaders to align strategies. Universities in the region facilitate this ecosystem by leveraging biotechnology and microbiology programs to bridge the gap between early-stage laboratory discovery and market-ready commercial applications.
Timeline
The regional sector earned $89.6 million in 2021.
The Fourth Annual Bioscience Summit was held in October 2026.
The Tech Race
The summit follows the pattern set by the University of North Dakota School of Medicine & Health Sciences' research portfolio, where academic discovery directly informs the region's commercial biotechnology activity. This event aligns regional efforts to maintain competitiveness in the high-stakes transition from microbiology research to commercial production.
Local professionals and business leaders can utilize the networking opportunities established during this summit to influence regional investment trajectories. The event provides a structured forum for stakeholders to address workforce challenges and access the pipeline of research coming from regional institutions.
The takeaway
The bioscience summit creates a concentrated space to translate academic findings into regional economic output. Industry participants should monitor upcoming workforce development initiatives for updates on how these academic-industry partnerships plan to address local staffing shortages.
Further reading
For more information on the regional biotech landscape, see Biotech.
Source note: This article includes information reported by WDAY Radio - AM 970 and FM 93.1.
Live Poll
Do you believe your local community should prioritize investment in the regional bioscience industry?
